PLoS ONE (Jan 2018)

miR-125b regulates chemotaxis and survival of bone marrow derived granulocytes in vitro and in vivo.

  • Chun-Wei Lee,
  • Caroline Schoenherr,
  • Karin Battmer,
  • Arnold Ganser,
  • Denise Hilfiker-Kleiner,
  • Sascha David,
  • Matthias Eder,
  • Michaela Scherr

DOI
https://doi.org/10.1371/journal.pone.0204942
Journal volume & issue
Vol. 13, no. 10
p. e0204942

Abstract

Read online

The evolutionary conserved miR-125b is highly expressed in hematopoietic stem cells (HSC) enhancing self-renewal and survival. Accordingly, over-expression of miR-125b in HSC may induce myeloproliferative neoplasms and leukemia with long latency. During hematopoietic cell maturation miR-125b expression decreases, and the function of miR-125b in mature granulocytes is not yet known. We here use transplantation of miR-125b over-expressing HSC into syngeneic hosts to generate and analyse miR-125b over-expressing granulocytes. Under steady state conditions, miR-125b over-expression inhibits granulocytic chemotaxis and LPS- but not PMA- and TNFα- induced cell death. Inflammatory signals modulate the effects of miR-125b over-expression as demonstrated in a sterile peritonitis and a polymicrobial sepsis model. In particular, survival of mice with miR-125b over-expressing granulocytes is significantly reduced as compared to controls in the polymicrobial sepsis model. These data demonstrate inflammation dependent effects of miR-125b in granulocytes and may point to therapeutic intervention strategies in the future.